This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Privacy Overview
One Response
The NIH in collaboration with Sanofi Pasteur is checking the drug in Stage I scientific trial of HSV-529 The trial is
expected to be finished in October 2016.